Navigation Links
TWi Pharmaceuticals Announces That It Will Sell Its Products in the U.S. Market, Originally Planned to Be Sold by Teva, Through Its Wholly-Owned Subsidiary, TWi Pharmaceuticals USA
Date:2/23/2015

TAIPEI, Feb. 23, 2015 /PRNewswire/ -- TWi Pharmaceuticals, Inc. ("TWi") (4180:Taiwan) today announced that TWi and Teva Pharmaceuticals ("Teva") have reached an agreement that will transfer the United States (U.S.) sales and distribution rights of TWi's generic versions of Megace® ES (megestrol acetate oral suspension, 625 mg/ 5 ml) and Lidoderm® (lidocaine patch, 5%) from Teva to TWi. TWi will distribute both products through its wholly-owned subsidiary, TWi Pharmaceuticals USA.

TWi has assembled a sales and distribution team in the U.S. and plans to launch several products in the U.S. under TWi's label this year.

"We are excited that we are going to sell our products under the TWi label and TWi will be able to enjoy all the profits derived from the products. We are optimistic about the change, which is consistent with the company strategy," said Dr. Calvin Chen, President of TWi Pharmaceuticals, Inc.

About TWi Pharmaceuticals, Inc.

TWi Pharmaceuticals, Inc. is a leading specialty pharmaceutical company based in Taipei, Taiwan, focusing on the development of high barrier generic prescription products ranging from oral controlled release dosage form to novel drug delivery systems including the utilization of nanoparticles, transdermal, and polymeric oral delivery systems. Leveraging its internal research and development capabilities, together with operational flexibility, process development, manufacturing and regulatory expertise, TWi Pharmaceuticals concentrates on products and technologies that present significant barriers to entry or offer Paragraph IV first-to-file or first-to-market opportunities in the United States. For more information of TWi Pharmaceuticals, please visit www.twipharma.com.

Contact :
Eric Lin 
Tel: +886-2-2657-3350 #407
email: eric.lin@twipharma.com


'/>"/>
SOURCE TWi Pharmaceuticals, Inc.
Copyright©2015 PR Newswire.
All rights reserved

Related medicine technology :

1. Cumberland Pharmaceuticals To Present At The UBS Global Healthcare Conference In New York
2. Valeant Pharmaceuticals Announces Resignation of Dr. Laurence Paul from Valeants Board of Directors
3. DelMar Pharmaceuticals, Inc. Provides Corporate Update for the Quarter Ended March 31, 2013
4. Access Pharmaceuticals Reports First Quarter Results
5. The Zacks Analyst Blog Highlights: Genomic Health, Sanofi, Regeneron Pharmaceuticals, Amgen and Isis Pharmaceuticals
6. Actinium Pharmaceuticals Clinical Results to be Presented at 8th International Symposium on Targeted Alpha Therapy Conference
7. AcelRx Pharmaceuticals to Present at the UBS Global Healthcare Conference
8. Aveo Pharmaceuticals, Inc. Sued by Investor
9. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses In Excess Of $100,000 Investing In AVEO Pharmaceuticals, Inc. To Contact The Firm
10. Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology
11. Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2020)... (PRWEB) , ... May 21, 2020 , ... ... aluminum services resource, donated its second COVID-19 drive-through testing shelter in Camden County, ... the Camden County Freeholders and Connor Strong & Buckelew and is located at ...
(Date:5/21/2020)... ... May 21, 2020 , ... Today Anyblock ... of the Corona SeroStatus app. Many facilities, cities, states/provinces, and countries are eager ... of coronavirus globally—including nearly 1.5 million in the United States alone—serious concerns remain ...
(Date:5/21/2020)... ... May 21, 2020 , ... Labyrinthe Labs has announced ... called Lefa . A soothing cream designed for fast-action relief of joint and ... phytocannabinoids proven to soothe and support tired joints and muscles. , According to ...
Breaking Medicine Technology:
(Date:5/21/2020)... ... May 21, 2020 , ... ... leader in cancer biomarker assays, announced today that Cigna has added ROMA® (Risk ... a global health service company dedicated to improving the health, well-being, and peace ...
(Date:5/21/2020)... Ga. (PRWEB) , ... May 21, 2020 , ... Friends ... District 35, has been endorsed by Planned Parenthood Southeast Advocates (PPSEA). ... who support family planning and the full range of reproductive health care. PPSEA educates ...
(Date:5/21/2020)... ... May 21, 2020 , ... The Rise of Mental Health and ... lot of complications and adjustments, needless to say, more complications. With rising deaths, more ... great depression it can be hard to escape and find peace. Adding to these ...
(Date:5/21/2020)... ... May 21, 2020 , ... JNL Technologies Inc. ... announced the release of the SafeHealth screening software. This tool allows companies ... for additional staff or the cost of additional paperwork management. , SafeHealth allows you ...
(Date:5/16/2020)... , ... May 15, 2020 , ... On May 21, T1V will host a webinar ... Institute of USC, and a contributor to CBS news, as we address COVID-19 and the ... in most parts of the country since March, many questions are left unanswered as we ...
Breaking Medicine News(10 mins):